Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The entry "Anti-pruritic effect via Stimutex-AS components" does not refer to a single molecular target such as a receptor, enzyme, or transporter. Instead, it describes the **anti-pruritic activity** achieved by a proprietary blend called **STIMU-TEX AS**, which is composed primarily of spent grain wax along with argan oil and shea butter extracts. This mixture is designed for topical use to relieve itching and reduce inflammation associated with various forms of irritated or sensitive skin. Mechanistically, STIMU-TEX AS acts by inhibiting key mediators involved in the inflammatory response—specifically blocking the induction of E-selectin on endothelial cells following histamine exposure (a marker for allergic reactions) and significantly decreasing interleukin 1-alpha release from inflamed human skin samples. These actions result in reduced vasodilation, vascular permeability, redness, swelling, and itching after exposure to irritants like histamine. Clinical studies have shown that topical application can reduce symptoms related to histamine-induced pruritus within minutes. However, since this is a cosmetic ingredient blend rather than a defined molecular target or receptor classically recognized as "druggable," it should not be classified as a therapeutic target per se but rather as an active ingredient mixture with anti-inflammatory properties used mainly in dermatological formulations for symptomatic relief.[1][3][5] In summary: > The term provided does not correspond to an individual molecular target but instead refers to the anti-pruritic effects mediated by the multi-component cosmetic ingredient STIMU-TEX AS—a blend acting through inhibition of inflammatory mediators such as E-selectin and interleukin 1-alpha.[1][3]
Blocks E-selectin expression on endothelial cells, reducing inflammatory response to histamine[1][3] - Decreases interleukin 1-alpha release in skin tissue[1][3]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Spent grain wax–based anti-pruritic complex (STIMU-TEX AS) (STIMU-TEX AS).